donald trump glp 1 Says He's Never Taken GLP-1 Weight Loss Drugs, but 'I Probably Should' Donald Trump Admits He's Open

Description

This is the only weight loss medication that works in the gut rather than the brain

Lilly said recently that sales of Zepbound have tripled so far this year to more than $9 billion

References Ai X, Yu P, Peng L, et al

It's not a good thing

Back to Journals Drug Design, Development and Therapy Volume 16 The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases Authors Cheng D, Yang S, Zhao X, Wang G Received 5 November 2021 Accepted for publication 18 February 2022 Published 14 March 2022 Volume 2022:16 Pages 665684 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Tuo Deng Dihe Cheng, Shuo Yang, Xue Zhao, Guixia Wang Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, Peoples Republic of China Correspondence: Guixia Wang